MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0016005
Biollios Pharmaceutical Private Limited
Biollios Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.58 Lakh
▼ 14% YoY
Net profit · FY 2025
₹2,100
Net margin 1.3%
EBITDA · FY 2025
₹2,800
EBITDA margin 1.8%
Authorised capital
₹40,000
Registered with MCA
Paid-up capital
₹40,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Biollios Pharmaceutical Private Limited
Data last updated:
Biollios Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC337319.
The company has an authorised share capital of ₹40,000 and a paid-up capital of ₹40,000. It is led by directors Sudhir Bhagwantrao Akre and Neeta Sudhir Akre.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No B – 2003 Plot No 6 Sector 11 Navi Mumbai Ghansoli, Maharashtra, India – 400701.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.58 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹2,100 (net margin 1.3%) and EBITDA of ₹2,800 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years.
Biollios Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0016005).
Company details
CIN U51909MH2020PTC337319
Registration Number 337319
Incorporation Date 06 February 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0016005
Recognitions & Rankings of Biollios Pharmaceutical
Contact details
Biollios Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressFlat No B – 2003 Plot No 6 Sector 11 Navi Mumbai Ghansoli, Maharashtra, India – 400701
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Biollios Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biollios Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Biollios Pharmaceutical Private Limited, buy the company report.
Financials of Biollios Pharmaceutical Private Limited
FY 2025 filings availableBiollios Pharmaceutical Private Limited reported revenue of ₹1.58 Lakh (down 14% YoY) for FY 2025.
Revenue · FY 2025
₹1.58 Lakh ▼ 14%
Net profit · FY 2025
₹2,100 margin 1.3%
EBITDA · FY 2025
₹2,800 margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 155%
3 years · compounded
▲ 29%
Revenue fell 14% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA rose 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,800 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,100 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biollios Pharmaceutical Private Limited, buy the company report.
Board of directors of Biollios Pharmaceutical Private Limited
Biollios Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Bhagwantrao Akre Also directs: Biozest Pharmacueticals Private Limited | Director | 06 Feb 2020 | 6 Years 8 Months | Current |
| Neeta Sudhir Akre | Director | 06 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Biollios Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Snacrave Foodtech Private Limited | ₹1.6 Lakh (FY 2025) | 111.0% | Indore, Madhya Pradesh, India | |||
| Celsia Marketing Private Limited | ₹1.6 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Neelkanth Megamart Private Limited | ₹1.59 Lakh (FY 2025) | Delhi, India | ||||
| RPM Silverline Private Limited | ₹1.59 Lakh (FY 2025) | -59.0% | New Delhi, Delhi, India | |||
| Yajnashri Foods Private Limited | ₹1.59 Lakh (FY 2025) | Aligarh, Uttar Pradesh, India | ||||
| Biollios Pharmaceutical Private Limitedthis company | ₹1.58 Lakh (FY 2025) | ₹2,100 | 1.3% | -14.0% | Mumbai, Maharashtra, India | |
| Anilabh Vyapaar Private Limited | ₹1.58 Lakh (FY 2025) | 54.0% | Kolkata, West Bengal, India | |||
| Costal Multitrading Private Limited | ₹1.58 Lakh (FY 2025) | -13.0% | Nagpur, Maharashtra, India | |||
| Goldenframe Talkies Private Limited | ₹1.57 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Fulare Solar Limited | ₹1.57 Lakh (FY 2025) | -27.0% | Nirmal, Maharashtra, India | |||
| Krushik Baramati Farmers Producer Company Limited | ₹1.56 Lakh (FY 2025) | Pune, Maharashtra, India |
To see the full peer comparison of Biollios Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biollios Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biollios Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biollios Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biollios Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Neeta Sudhir Akre was appointed as Director on 06 Feb 2020.
AGM
Biollios Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biollios Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Neeta Sudhir Akre was appointed as Director.
Appointed
Sudhir Bhagwantrao Akre was appointed as Director.
Incorporation
06 Feb 2020
Biollios Pharmaceutical Private Limited was registered on 06 Feb 2020 with Roc Mumbai & aged 6 years 8 months as per MCA records.
Frequently asked questions
Biollios Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 February 2020 (6+ years old) and is registered under CIN U51909MH2020PTC337319.
Biollios Pharmaceutical has 2 current directors:
- Sudhir Bhagwantrao Akre - Director
- Neeta Sudhir Akre - Director
The latest financial statements of Biollios Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Biollios Pharmaceutical is U51909MH2020PTC337319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biollios Pharmaceutical was incorporated on 06 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Biollios Pharmaceutical by revenue are Snacrave Foodtech Private Limited, Celsia Marketing Private Limited, Neelkanth Megamart Private Limited, RPM Silverline Private Limited, Yajnashri Foods Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Neeta Sudhir Akre was appointed as Director on 06 Feb 2020. Sudhir Bhagwantrao Akre was appointed as Director on 06 Feb 2020.
Yes, Biollios Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0016005).
The registered office of Biollios Pharmaceutical is at Flat No B – 2003 Plot No 6 Sector 11 Navi Mumbai Ghansoli, Maharashtra, India – 400701.
Biollios Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Biollios Pharmaceutical can be reached at its registered office: Flat No B – 2003 Plot No 6 Sector 11 Navi Mumbai Ghansoli, Maharashtra, India – 400701.